Barchart Demo Center

Overview

Stocks

Stock Screeners

ETFs

Futures

Funds

Fund Screeners

Foreign Exchange

Sectors

News

Financial Calculators

Embedded Widgets

Portfolio

Screener

JSON Feeds

Symbol Overview

United States|Canada
English|French

Karyopharm Therapeut

(NASDAQ: KPTI)
Add to Portfolio
+0.82 (+7.43%)
as of Sep 16, 2019

Last 11.85
Change +0.82 (+7.43%)
Open 11.25
Prev. Close 11.03
Today's Range
11.19
12.34
52wk Range
3.92
19.19
Volume 3,936,973
Avg Volume 1,558,770
Sector SIC-2834 Pharmaceutical Preparations

Perfomance Comparison

Name Today 3-Month 1-Year
KPTI +7.43% +34.51% -36.70%
DJIA -0.52% +0.57% +3.53%
S&P 500 -0.31% +0.25% +3.20%

Key Statistics

Annual EPS -3.55
Dividend Yield 0.00%
P/E Ratio N/A
Market Capitalization, $K 655,120
Weighted Alpha -1.32
Standard Deviation +1.96
Profit Margin N/A
Beta 2.41

Growth Rates

YTD +26.47%
1-Year -41.08%
3-Year +18.60%
5-Year -72.13%

Opinion

Sell Hold Buy

Recent Headlines

Glancy Prongay & Murray Reminds Investors of Looming

GlobeNewswire via COMTEX - 01:30PM EDT
Glancy Prongay & Murray LLP ("GPM") reminds investors of the upcoming September 23, 2019 deadline to file a lead plaintiff motion in the class action filed on behalf of Karyopharm Therapeutics, Inc. ("Karyopharm" or the "Company")(full story)
KPTI: 11.85 (+0.82)

Deadline Reminder: The Law Offices of Howard G. Smith

GlobeNewswire via COMTEX - 10:30AM EDT
Law Offices of Howard G. Smith reminds investors of the upcoming September 23, 2019 deadline to file a lead plaintiff motion in the class action filed on behalf of Karyopharm Therapeutics, Inc. ("Karyopharm" or the "Company") (NAS(full story)
KPTI: 11.85 (+0.82)

7-DAY DEADLINE ALERT: The Schall Law Firm Announces

GlobeNewswire via COMTEX - 08:50AM EDT
The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Karyopharm Therapeutics Inc. ("Karyopharm" or "the Company") (NASDAQ: KPTI) for violations of §(full story)
KPTI: 11.85 (+0.82)

Karyopharm Enters Into Royalty Agreement with

GlobeNewswire via COMTEX - 07:00AM EDT
Karyopharm Therapeutics Inc. (Nasdaq:KPTI), an oncology-focused pharmaceutical company, today announced its entry into a royalty agreement with HealthCare Royalty Partners (HCR) for up to $150 million to support the ongoing develo(full story)
KPTI: 11.85 (+0.82)

SHAREHOLDER ALERT: CLAIMSFILER REMINDS EGBN, KPTI, LB,

GlobeNewswire via COMTEX - Fri Sep 13, 10:50PM EDT
ClaimsFiler, a FREE shareholder information service, reminds investors of pending deadlines in the following securities class action lawsuits:(full story)
NGHC: 24.23 (-0.16), LB: 19.44 (+0.57), KPTI: 11.85 (+0.82), EGBN: 45.44 (-0.05)